...
首页> 外文期刊>The American Journal of Cardiology >Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non-Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)
【24h】

Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Non-Infarct-Related Arteries in Patients With Acute Myocardial Infarction (from the COREA-AMI Registry)

机译:经皮冠状动脉介入治疗对急性心肌梗死患者非梗死相关动脉中慢性完全阻塞的影响(来自COREA-AMI注册中心)

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic, total occlusion (CTO) in a non infarct-related artery (IRA) is an independent predictor of clinical outcomes in patients with acute myocardial infarction (AMI). This study evaluated the impact of successful percutaneous coronary intervention (PCI) for CTO of a non-IRA on the long-term clinical outcomes in patients with AMI. A total of 4,748 patients with AMI were consecutively enrolled in the Convergent Registry of Catholic and Chonnam University for AMI registry from January 2004 to December 2009. We enrolled 324 patients with CTO in a non-IRA. To adjust for baseline differences, propensity matching (96 matched pairs) was used to compare successful PCI and occluded CTO for the treatment of CTO in non-IRA. The primary clinical end points were all-cause mortality and a composite of the major adverse cardiac events, including cardiac death, MI, stroke, and any revascularization during the 5-year follow-up. Patients who received successful PCI for CTO of non-IRA had lower rates of all-cause mortality (16.7% vs 32.3%, hazard ratio 0.459, 95% CI 0.251 to 0.841, p = 0.012) and major adverse cardiac events (21.9% vs 55.2%, hazard ratio 0.311, 95% CI 0.187 to 0.516, p <0.001) compared with occluded CTO group. Subgroup analyses revealed that successful PCI resulted in a better mortality rate in patients with normal renal function compared to patients with chronic kidney disease (p = 0.010). In conclusion, successful PCI for CTO of non-IRA is associated with improved long-term clinical outcomes in patients with AMI. (C) 2016 Elsevier Inc. All rights reserved.
机译:非梗死相关动脉(IRA)中的慢性完全阻塞(CTO)是急性心肌梗死(AMI)患者临床结局的独立预测因子。这项研究评估了非IRA的CTO成功经皮冠状动脉介入治疗(PCI)对AMI患者长期临床结局的影响。从2004年1月至2009年12月,共有4,748例AMI患者被连续纳入天主教和春南大学的融合注册表进行AMI登记。我们在非IRA中纳入324例CTO患者。为了调整基线差异,使用倾向匹配(96对匹配)比较成功的PCI和闭塞的CTO在非IRA中治疗CTO。主要临床终点是全因死亡率和主要不良心脏事件(包括心脏死亡,MI,中风和5年随访期间的任何血运重建)的综合。非IRA的CTO成功接受PCI的患者全因死亡率较低(16.7%vs 32.3%,危险比0.459,95%CI 0.251 to 0.841,p = 0.012)和主要的不良心脏事件(21.9%vs与封闭的CTO组相比,危险率为55.2%,危险比为0.311,95%CI为0.187至0.516,p <0.001)。亚组分析显示,与慢性肾脏病患者相比,成功进行PCI可使肾功能正常的患者死亡率更高(p = 0.010)。总之,成功的PCI用于非IRA的CTO可以改善AMI患者的长期临床疗效。 (C)2016 Elsevier Inc.保留所有权利。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号